2000
DOI: 10.1016/s0735-1097(99)00608-7
|View full text |Cite
|
Sign up to set email alerts
|

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction

Abstract: Even moderate degrees of renal insufficiency are independently associated with an increased risk for all-cause mortality in patients with heart failure, largely explained by an increased risk of heart failure progression. These data suggest that, rather than simply being a marker of the severity of underlying disease, the adequacy of renal function may be a primary determinant of compensation in patients with heart failure, and therapy capable of improving renal function may delay disease progression.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

22
464
2
31

Year Published

2001
2001
2018
2018

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 775 publications
(519 citation statements)
references
References 11 publications
22
464
2
31
Order By: Relevance
“…Additionally, the increased risk of bleeding may be due to platelet dysfunction, prolonged bleeding time, and small vessel disease associated with CKD 27, 28. Overall, CKD may be associated with adverse outcomes in HF, as it is a marker of more severe HF, greater symptom burden, and/or coexistent disease 1, 2, 29. The poorer survival in patients with CKD and HF may also reflect the reduced likelihood of being prescribed evidence‐based therapies,29, 30 as CKD is often viewed as a contraindication to some therapies,2, 29 including thromboprophylactic therapies 31.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Additionally, the increased risk of bleeding may be due to platelet dysfunction, prolonged bleeding time, and small vessel disease associated with CKD 27, 28. Overall, CKD may be associated with adverse outcomes in HF, as it is a marker of more severe HF, greater symptom burden, and/or coexistent disease 1, 2, 29. The poorer survival in patients with CKD and HF may also reflect the reduced likelihood of being prescribed evidence‐based therapies,29, 30 as CKD is often viewed as a contraindication to some therapies,2, 29 including thromboprophylactic therapies 31.…”
Section: Discussionmentioning
confidence: 99%
“…Overall, CKD may be associated with adverse outcomes in HF, as it is a marker of more severe HF, greater symptom burden, and/or coexistent disease 1, 2, 29. The poorer survival in patients with CKD and HF may also reflect the reduced likelihood of being prescribed evidence‐based therapies,29, 30 as CKD is often viewed as a contraindication to some therapies,2, 29 including thromboprophylactic therapies 31. This is correspondingly reflected in randomized trials testing the efficacy and safety of therapies, where patients with CKD are often excluded, resulting in clinicians being challenged in how to choose the optimal treatment for these patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Chronic renal dysfunction has a negative effect on cardiac function and chronic kidney disease (CKD) is an important predictor of adverse outcome and increased morbidity in patients with chronic heart failure (CHF). [14][15][16][17] A stage classification for CKD has been proposed for assessing the degree of severity of renal dysfunction, and recent evidence indicates that a moderate decrease in glomerular filtration rate (GFR) to <60 ml/min/1.73 m2 of body surface area is associated with an adverse outcome in CHF patients. [14][15][16] Diastolic dysfunction is frequently observed in CHF patients with or without CKD [18] and (tissue Doppler imaging) TDI has improved assessment of this condition.…”
Section: Introductionmentioning
confidence: 99%
“…[14][15][16][17] A stage classification for CKD has been proposed for assessing the degree of severity of renal dysfunction, and recent evidence indicates that a moderate decrease in glomerular filtration rate (GFR) to <60 ml/min/1.73 m2 of body surface area is associated with an adverse outcome in CHF patients. [14][15][16] Diastolic dysfunction is frequently observed in CHF patients with or without CKD [18] and (tissue Doppler imaging) TDI has improved assessment of this condition. [19] Left ventricular diastolic dysfunction affects morbidity and mortality in CHF patients with CKD, and echocardiography may provide additional diagnostic data on ventricular function.…”
Section: Introductionmentioning
confidence: 99%